U-BX Technology Ltd. Price & Performance (UBXG)

President Marcos of the Philippines has chosen a digital technology expert to lead the Department of Information and Communications Technology (DICT). The new appointee is expected to drive the country's digital transformation efforts, focusing on enhancing connectivity, cybersecurity, and digital infrastructure.1

Chardan Capital has upgraded its earnings forecast for Unity Biotechnology, predicting a smaller loss for FY2025. Analysts now estimate the company will post a loss of $0.72 per share, an improvement from the previous $0.74 forecast. The firm maintains a 'Buy' rating with a price target of $6.00.2

HC Wainwright has revised its earnings outlook for Unity Biotechnology, projecting a smaller loss of $1.45 per share for FY2025, up from a previous estimate of $1.71. The firm also expects the company to achieve profitability by FY2027. Unity Biotechnology remains rated as a 'Buy' with an $8.00 price target.3